A Revised Standard for Diagnosis
A large international study published in eClinicalMedicine has concluded that a newly proposed global definition of clinical obesity identifies substantially fewer children as obese than the body mass index criterion currently in widespread use, with findings that could reshape how clinicians assess and manage excess body fat across the life course.
The research, led by the Murdoch Children’s Research Institute (MCRI) and drawing on data from 786,557 participants across Australia, Canada, Estonia, Finland, the Netherlands, the United Kingdom and the United States, is the first study to examine the prevalence of clinical obesity from early childhood through to older age using a consistent methodological framework.
Under the new Lancet Commission definition of clinical obesity, the condition is diagnosed not by weight relative to height alone but by whether excess body fat is accompanied by measurable symptoms of obesity-related illness or by limitations in the performance of daily activities — a standard that demands considerably more than a single anthropometric calculation.
Striking Divergence in Childhood Prevalence
The study found that clinical obesity affected only 2.1 to 4.9 per cent of children and adolescents, compared with 7 to 10.8 per cent classified as obese under conventional BMI criteria — a divergence that carries direct implications for how many young patients are referred for intervention, prescribed weight-loss medications, or placed on dietary regimens.
Dr Danielle Longmore of MCRI’s Inflammatory Origins Group, who led the research, noted that BMI retained utility as a population-level surveillance tool but failed to capture the full complexity of an individual’s metabolic health. The new definition, she argued, would allow clinicians to make more precisely calibrated decisions about when and how to intervene.
“This definition is a starting point for looking at obesity in a way that better reflects what healthcare professionals are already seeing in practice,” Dr Longmore said. “People can have a similar BMI but develop very different health outcomes related to excess body fat.”
A Different Picture in Later Life
The pattern reverses markedly in older age groups. Although clinical obesity was less prevalent than BMI-defined obesity during childhood and early adulthood, its prevalence rose steadily through the adult years, surpassing BMI-defined obesity from the 55-to-64 age bracket onwards and reaching 52 per cent among adults aged 65 to 74 — a figure that underscores the growing burden of obesity-related illness in ageing populations.
The study also identified a sex-linked pattern: clinical obesity was more prevalent among men during early-to-mid adulthood, while women experienced higher rates later in life, a distinction that may have consequences for the timing and targeting of clinical interventions.
Professor David Burgner, leader of MCRI’s Inflammatory Origins Group, emphasised that childhood and adolescence represented a critical window for reducing the long-term consequences of excess body fat, including cardiovascular disease, type 2 diabetes, hypertension, stroke and certain cancers. Understanding which children already show signs of obesity-related complications, he said, would help inform future prevention and treatment strategies.
Methodological Caveats and Next Steps
Professor Burgner nonetheless urged caution, noting that none of the cohort datasets contained complete information on all diagnostic criteria specified under the Lancet Commission definition. Future longitudinal studies, he said, would be necessary to establish the true prevalence of clinical obesity with greater precision.
The data underpinning the analysis were drawn from eleven established cohort studies, including the Avon Longitudinal Study of Parents and Children, the Estonian Biobank, the UK Biobank, the National Health and Nutrition Examination Survey and the Cardiovascular Risk in Young Finns Study, among others. Contributing institutions spanned the University of Toronto, Erasmus University, the University of Melbourne, McMaster University, Deakin University and the University of Sydney, reflecting the genuinely multinational character of the effort.
The findings arrive at a moment when health systems in high-income countries face mounting pressure to allocate obesity-related resources efficiently. A diagnostic framework that distinguishes more rigorously between excess body weight and clinically significant disease may, if validated by further research, offer policymakers and commissioners a more defensible basis on which to prioritise care.